European Union regulators are set to order Illumina to sell cancer detection test maker Grail, which it had acquired for $7.1 billion in 2021, the Financial Times reported on Monday citing three people with knowledge of the matter.
https://finance.yahoo.com/news/eu-regulators-order-illumina-sell-121559425.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.